Format

Send to

Choose Destination
Nanomedicine (Lond). 2012 Mar;7(3):321-5. doi: 10.2217/nnm.12.13.

Kindling translational cancer nanotechnology research.

Author information

1
Office of Cancer Nanotechnology Research, Center for Strategic Scientific Initiatives, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
PMID:
22385196
DOI:
10.2217/nnm.12.13
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center